全球□治療市場：按產品類型、應用、給藥途徑、地區 - 規模、份額、展望、機會分析，2023-2030 年

由於新的製造、修飾和分析技術，多□藥物的開發正在經歷巨大的增長。 已經使用化學和生物學方法生成和修飾了□，新穎的設計和遞送策略克服了它們固有的缺點並使該領域不斷取得進展。 已經獲得併研究了涵蓋心臟代謝、免疫學、皮膚和腫瘤學等各種治療領域的多種天然和修飾□。 隨著 21 世紀的到來，多□藥物開發進入了一個新時代，結構生物學、重組生物學以及新的合成和分析技術的進步顯著加快了這一進程。 建立了包括多□藥物發現、藥物設計、多□合成、結構修飾和活性評價在內的先進的多□藥物開發體系。

治療性□是一類獨特的藥物，由氨基酸序列組成，通常分子量為 500-5000 Da。

市場動態

市場先驅們正致力於開發新穎和創新的□療法，通過增強的生物相容性和強大的治療功效為目標患者提供量身定制的解決方案。 癌症、心血管疾病和糖尿病患病率的增加預計將在預測期內推動□治療市場的增長。

為了擴大產品組合，市場的主要參與者越來越多地採用聯盟等有機增長戰略，預計這將在預測期內推動市場增長。 例如，2023年1月，全球最大的製藥公司禮來公司與全球醫療保健公司默克公司就多□靶向藥物遞送合作，收購生物製藥公司PeptiDream，宣布合作。

這項研究的主要特點

• 本報告對全球□治療市場進行了深入分析，展示了以 2022 年為基準年的預測期（2023 年至 2030 年）的市場規模和復合年增長率 (CAGR%) 的增長情況。
• 它揭示了各個細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 本文根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，介紹了全球□治療市場的主要參與者。
• 本次調查涵蓋的主要公司：Teva Pharmaceutical Industries Ltd、Novo Nordisk A/S、OPKO Health, Inc.、Lilly、Hanmi Pharm.Co.、Sanofi、Circle Pharma、Pfizer Inc.、Novartis AG、PeptiDream Inc.。 , Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球□治療市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球□治療市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫

第二章市場範圍

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 市場概況：按應用分類
  • 按給藥途徑劃分的市場概況
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場吸引力分析
  • 市場機會
• 產品發布
• 合併/收購/聯合研究
• 監管準則和合規性
• 主要發展
• 害蟲分析
• 技術概況
• 對 PORTER 的分析
• 價格分析 (2021)

第 4 章全球□治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 經濟影響
• COVID-19 流行病學
• 對供需的影響

第 5 章全球□治療市場，按產品類型，2017-2030

• 品牌□
• 通用□

第 6 章全球□治療市場，按應用，2017-2030

• 癌症
• 心血管疾病
• 代謝綜合徵（代謝性疾病
• 呼吸系統疾病
• 感染
• 其他

第 7 章按給藥途徑劃分的全球□治療市場，2017-2030

• 口服給藥
• 腸外給藥
• 其他

第 8 章全球□治療市場，按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• Teva Pharmaceutical Industries Ltd.
• Novo Nordisk A/S
• OPKO Health, Inc.
• Lilly
• Hanmi Pharm.Co.
• Sanofi
• Circle Pharma
• Pfizer Inc.
• Novartis AG
• PeptiDream Inc.
• Amgen Inc.
• AstraZeneca
• Bachem Holding AG
• CordenPharma International
• Ipsen Pharma
• Merck KGaA
• PolyPeptide Group
• Bayer AG

第 10 章

• 調查方法
• 關於出版商

Peptide drug development has grown immensely due to new manufacturing, modification, and analytical techniques. Peptides are generated and modified using both chemical and biological methods, along with new design and delivery strategies that overcomes the inherent drawbacks of peptide and enables continued progress in this field. A wide variety of natural and modified peptides have been obtained and studied covering multiple therapeutic area such as cardio metabolic, immunology and dermatology, oncology, etc. Peptide drug development entered a new era with the advent of the 21st century, since then advances in structural biology, recombinant biologics, and new synthetic and analytic technologies have significantly accelerated the process. A sophisticated system of peptide drug development has been established, including peptide drug discovery, drug design, peptide synthesis, structural modification, and activity evaluation.

Therapeutic peptides are a unique class of pharmaceuticals composed of an ordered series of amino acids, typically with molecular weights between 500 and 5000 Da.

Market Dynamics

Market players are developing novel and innovative peptide therapeutics to provide tailored solutions for target patients, by enhancing biocompatibility and potent therapeutic efficacy. Increasing prevalence of cancer, cardiovascular diseases, and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period.

Increasing adoption of organic growth strategies such as collaborations by key players in the market in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2023, Lilly, one of the world's largest pharmaceutical companies, and Merck, a global healthcare company, announced their partnership for peptide-targeted drug delivery, collaborating to acquire PeptiDream which is a biopharmaceutical company.

Key features of the study:

• This report provides in-depth analysis of the global peptide therapeutics market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global peptide therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health, Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide therapeutics market

Detailed Segmentation:

• Global Peptide Therapeutics Market, By Product Type:
  • Branded Peptide
  • Generic Peptide
• Global Peptide Therapeutics Market, By Application:
  • Cancer
  • Cardiovascular diseases
  • Metabolic diseases
  • Respiratory diseases
  • Infectious diseases
  • Others
• Global Peptide Therapeutics Market, By Route of Administration:
  • Oral Administration
  • Parenteral Administration
  • Others
• Global Peptide Therapeutics Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S
  • OPKO Health, Inc.
  • Lilly
  • Hanmi Pharm.Co.
  • Sanofi
  • Circle Pharma
  • Pfizer Inc.
  • Novartis AG
  • PeptiDream Inc.
  • Amgen Inc.
  • AstraZeneca
  • Bachem Holding AG
  • CordenPharma International
  • Ipsen Pharma
  • Merck KGaA
  • PolyPeptide Group
  • Bayer AG

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER's Analysis
• Pricing Analysis (2021)

4. Global Peptide Therapeutics Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Peptide Therapeutics Market, By Product Type, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Branded Peptide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Generic Peptide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Peptide Therapeutics Market, By Application, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cardiovascular Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Metabolic Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Respiratory Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Infectious Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Peptide Therapeutics Market, By Route of Administration, 2017-2030, (US$ Million)

• Oral Administration
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Parenteral Administration
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Peptide Therapeutics Market, By Region, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017-2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novo Nordisk A/S
• OPKO Health, Inc.
• Lilly
• Hanmi Pharm.Co.
• Sanofi
• Circle Pharma
• Pfizer Inc.
• Novartis AG
• PeptiDream Inc.
• Amgen Inc.
• AstraZeneca
• Bachem Holding AG
• CordenPharma International
• Ipsen Pharma
• Merck KGaA
• PolyPeptide Group
• Bayer AG

10. Section

• Research Methodology
• About Us